Alembic gets USFDA nod for Tizanidine hydrochloride capsules used to treat spasticity
Posted by
www.biotecnika.org
"The company has received final approval from the US Food & Drug
Administration (USFDA) for its Abbreviated New Drug Application (ANDA)
Tizanidine Hydrochloride Capsules, 2 mg, 4 mg, and 6 mg," the drug
firm said in a regulatory filing.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-gets-usfda-nod-for-tizanidine-hydrochloride-capsules-used-to-treat-spasticity/articleshow/73265604.cms
Subscribe to:
Post Comments (Atom)
Post a Comment